Allogene Therapeutics, Inc. · NASDAQ:ALLO

BlackRock, Inc. reported a 5.30% stake in Allogene Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 17, 2025

BlackRock, Inc. reported a 5.30% stake in Allogene Therapeutics, Inc., 11,450,079 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).

Stake
5.30%
Shares
11,450,079
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.5.30%11,450,079

Source

View original at SEC

Related